Adverum Biotechnologies
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-3,600 | $0 |
Gross Profit | -465 | -535 | -683 | |
EBITDA | -47,187 | -49,320 | -47,538 | |
EBIT | -47,652 | -49,855 | -48,221 | |
Net Income | -47,652 | -49,191 | -47,019 | -60,530 |
Net Change In Cash | 0 | 0 | -3,600 | 0 |
Free Cash Flow | -28,257 | -38,887 | -42,991 | -28,310 |
Cash | 26,060 | 42,418 | 49,161 | 60,652 |
Basic Shares | 23,487 | 21,010 | 20,938 | 20,848 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,000 | $3,600 | $3,600 | $7,500 |
Gross Profit | 1,000 | 3,600 | -6,528 | 7,500 |
EBITDA | -135,506 | -123,298 | -150,607 | -141,477 |
EBIT | -139,159 | -128,942 | -157,135 | -146,122 |
Net Income | -130,927 | -122,116 | -154,536 | -145,540 |
Net Change In Cash | 1,000 | 3,600 | 3,600 | 7,500 |
Cost of Revenue | -26,725 | |||
Free Cash Flow | -92,850 | -91,710 | -119,907 | -122,954 |
Cash | 60,652 | 75,000 | 68,431 | 34,195 |
Basic Shares | 19,782 | 57,977 | 57,977 | 98,361 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$2.03 |
2025-06-30 | -$2.34 |
2025-03-31 | -$1.95 |
2024-12-31 | -$1.96 |
